Translational Development Acquisition TDACW
NASDAQ TDACW
$1.60 -0.25 (-13.51%)
As of: Sep 9, 2026 · 2:59 PM EDT

Translational Development Acquisition (TDACW) Net Cash Flow (QoQ) (2024 - 2026)

Analysis

Translational Development Acquisition (TDACW) Net Cash Flow (QoQ) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Evercore 11.52 Bn 9.43 Bn 975.67 Mn
2 Jefferies Financial 11.24 Bn -4.17 Bn 3.09 Bn
3 Houlihan Lokey 9.53 Bn 8.45 Bn -
4 Cluster Group Holdings 8.00 Bn 8.00 Bn -
5 PJT Partners 6.94 Bn 6.99 Bn 481.98 Mn
6 Moelis 6.06 Bn 5.99 Bn -
7 Piper Sandler Companies 5.20 Bn 5.09 Bn -
8 Lazard 4.97 Bn 3.99 Bn -
9 BRBI BR Partners 3.44 Bn 3.32 Bn 16.77 Mn
10 Translational Development Acquisition 52.67 Mn 52.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -534,245.30%
Mar 31, 2026 70.30%
Dec 31, 2025 80.29%
Sep 30, 2025 48.58%
Jun 30, 2025 26.01%
Mar 31, 2025 -100.13%
Dec 31, 2024 90,517.73%